Phase III Study of Pharos Vitesse Neurovascular Stent System Compared to Best Medical Therapy for the Treatment of Ischemic Disease
The main objective of this study is to prospectively evaluate the safety, probable benefit, and effectiveness of the PHAROS Vitesse Neurovascular Stent System in a multicenter, randomized clinical trial.
A secondary objective of this study is to evaluate the impact of stenting in the neurovasculature to treat cerebral ischemia on other outcomes such as hospital length of stay, charges, and costs.
100 项与 Codman & Shurtleff, Inc. /Surgical Instruments Business/ 相关的临床结果
0 项与 Codman & Shurtleff, Inc. /Surgical Instruments Business/ 相关的专利(医药)
100 项与 Codman & Shurtleff, Inc. /Surgical Instruments Business/ 相关的药物交易
100 项与 Codman & Shurtleff, Inc. /Surgical Instruments Business/ 相关的转化医学